Results 11 to 20 of about 41,330 (277)
Pediatric ITP: is it different from adult ITP? [PDF]
AbstractImmune thrombocytopenia (ITP) has historically been thought to occur in 2 distinct forms: childhood ITP and adult ITP. This division is based largely on the presumption that childhood ITP is often benign and self-limited, whereas ITP in adults tends to be more chronic and difficult to treat.
Amanda B. Grimes, Jenny M. Despotovic
openaire +4 more sources
Fei Song,1,2 Hanny Al-Samkari2,3 1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; 2Harvard Medical School, Boston, MA, USA; 3Division of Hematology, Massachusetts General Hospital, Boston, MA, USACorrespondence: Hanny Al ...
Song F, Al-Samkari H
doaj +2 more sources
Tony Zitek,1,2 Luke Weber,1 Dominique Pinzon,1 Nicole Warren1– 3 1Department of Emergency Medicine, Mount Sinai Medical Center, Miami Beach, FL, USA; 2Department of Emergency Medicine, Herbert Wertheim College of Medicine at Florida International ...
Zitek T, Weber L, Pinzon D, Warren N
doaj +2 more sources
Is
Immune thrombocytopenia (ITP) represents the epitome of acquired bleeding diseases for the hematologist. Stemming from the interest for the safety of thrombopoietin‐receptor agonists (TPO‐ra) romiplostim and eltrombopag, recent data have investigated if thrombotic risk is also increased in this disorder.
F. Rodeghiero
openaire +4 more sources
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Key Points SARS-CoV-2 vaccines are generally safe in patients with preexisting ITP but thrombocytopenia exacerbation may occur and requires monitoring. Splenectomy and past use of 5 or more therapies predict higher risk of worsening thrombocytopenia in ...
Eun-Ju Lee+18 more
semanticscholar +2 more sources
Chronic primary immune thrombocytopenia (ITP) can today benefit from multiple therapeutic approaches with proven clinical efficacy, including rituximab, thrombopoietin receptor agonists (TPO-RA), and splenectomy.
N. Vianelli+12 more
semanticscholar +1 more source
Novel Therapies to Address Unmet Needs in ITP
Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current corticosteroid-based ITP therapies are able to improve platelet counts, up to 70% of subjects with an ITP ...
M. Mingot-Castellano+12 more
semanticscholar +1 more source
Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and ...
Muzamil Jawed+4 more
semanticscholar +1 more source
Platelets in ITP: Victims in Charge of Their Own Fate?
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder. The pathophysiological mechanisms leading to low platelet levels in ITP have not been resolved, but at least involve autoantibody-dependent and/or cytotoxic T cell mediated platelet ...
V. Nelson+9 more
semanticscholar +1 more source
Bleeding Diseases in Orthopedic Clinical Approach [PDF]
Aim Bleeding diseases are rarely studied as complications of an orthopedic surgical procedure with postsurgical bleeding. This study aims to present a retrospective cohort-study about the approach to bleeding disorders in an ordinary orthopedic clinic ...
Kadri Yildiz, Vahit Yildiz
doaj +1 more source